Amgen (AMGN) Financials
Amgen (AMGN) Historical Financial Statements and Key Metrics for 1986 - 2021
Full Amgen financials for 1986 - 2021 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Amgen Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2021-Mar-31 | 5,901 | 4,411 (74.8 %) | 2,129 (36.1 %) | 1,646 (27.9 %) | 2,970 | 2.83 |
| 2020-Dec-31 | 6,634 | 5,037 (75.9 %) | 2,008 (30.3 %) | 1,615 (24.3 %) | 2,881 | 2.76 |
| 2020-Sep-30 | 6,423 | 4,862 (75.7 %) | 2,453 (38.2 %) | 2,021 (31.5 %) | 3,354 | 3.43 |
| 2020-Jun-30 | 6,206 | 4,718 (76.0 %) | 2,323 (37.4 %) | 1,803 (29.1 %) | 3,253 | 3.05 |
| 2020-Mar-31 | 6,161 | 4,648 (75.4 %) | 2,355 (38.2 %) | 1,825 (29.6 %) | 3,252 | 3.07 |
| 2019-Dec-31 | 6,197 | 4,944 (79.8 %) | 2,048 (33.0 %) | 1,703 (27.5 %) | 2,750 | 2.85 |
| 2019-Sep-30 | 5,737 | 4,701 (81.9 %) | 2,476 (43.2 %) | 1,968 (34.3 %) | 2,984 | 3.27 |
Full historical income statements for 1986 - 2021 is included in the
US Historical Financials dataset.
Amgen Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2021-Mar-31 | 62,539 | 53,205 | 32,685 | 9,334 | 10,566 |
| 2020-Dec-31 | 62,948 | 53,539 | 32,986 | 9,409 | 10,647 |
| 2020-Sep-30 | 64,637 | 53,678 | 34,287 | 10,959 | 12,360 |
| 2020-Jun-30 | 65,011 | 54,352 | 34,224 | 10,659 | 11,421 |
| 2020-Mar-31 | 61,669 | 52,184 | 31,848 | 9,485 | 8,012 |
| 2019-Dec-31 | 59,707 | 50,034 | 29,903 | 9,673 | 8,911 |
| 2019-Sep-30 | 59,535 | 48,608 | 29,791 | 10,927 | 20,853 |
Full historical balance sheet data for 1986 - 2021 is included in the
US Historical Financials dataset.
Amgen Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2021-Mar-31 | 2,104 | -319 | -1,939 | 1,938 |
| 2020-Dec-31 | 2,153 | -1,384 | -3,590 | 1,980 |
| 2020-Sep-30 | 3,368 | -1,628 | -1,798 | 3,233 |
| 2020-Jun-30 | 2,842 | -2,159 | 775 | 2,684 |
| 2020-Mar-31 | 2,134 | -230 | -254 | 1,992 |
| 2019-Dec-31 | 2,514 | -5,963 | -1,929 | 2,326 |
| 2019-Sep-30 | 3,377 | 5,372 | -2,859 | 3,207 |
Full historical cash flow data for 1986 - 2021 is included in the
US Historical Financials dataset.
Amgen Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2021-Mar-31 | 143,563 | 170,136 | 24.33 | 21.80 | 15.38 |
| 2020-Dec-31 | 134,503 | 161,223 | 20.27 | 20.82 | 14.30 |
| 2020-Sep-30 | 148,684 | 173,884 | 23.15 | 18.39 | 13.57 |
| 2020-Jun-30 | 138,686 | 163,765 | 22.35 | 19.23 | 13.01 |
| 2020-Mar-31 | 119,611 | 143,772 | 19.41 | 16.39 | 12.61 |
| 2019-Dec-31 | 142,955 | 166,821 | 23.07 | 20.99 | 14.78 |
| 2019-Sep-30 | 115,912 | 134,288 | 20.20 | 14.72 | 10.61 |
Full historical valuation and operating metrics for 1986 - 2021 are included in the
US Historical Financials dataset.